{"podcast":{"title":"Lung Cancer Considered","slug":"lung-cancer-considered-246259","podcast_index_feed_id":246259,"rss_url":"https://feeds.soundcloud.com/users/soundcloud:users:608921562/sounds.rss","website_url":"https://www.iaslc.org/","image_url":"https://i1.sndcdn.com/avatars-ou1Me3OziDCCzH26-Z5d0QQ-original.jpg","author":"IASLC","episode_count":410,"summary":"Dr. Stephen Liu and Dr. Narjust Florez host Lung …","last_synced_at":"2026-09-25T00:18:10.880807+00:00","page_url":"https://stenobird.com/podcast/lung-cancer-considered-246259"},"episodes":[{"title":"LCC in Czech: WCLC 2026 Highlights","slug":"lcc-in-czech-wclc-2026-highlights","published_at":"2026-09-24T11:03:37+00:00","page_url":"https://stenobird.com/podcast/lung-cancer-considered-246259/lcc-in-czech-wclc-2026-highlights","url":"https://soundcloud.com/lungcancerconsidered/lcc-in-czech-wclc-2026","duration_seconds":659,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/lung-cancer-considered-246259/episodes/lcc-in-czech-wclc-2026-highlights/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/lung-cancer-considered-246259/lcc-in-czech-wclc-2026-highlights.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"LCC in Spanish: WCLC 2026 Highlights","slug":"lcc-in-spanish-wclc-2026-highlights","published_at":"2026-09-17T14:08:14+00:00","page_url":"https://stenobird.com/podcast/lung-cancer-considered-246259/lcc-in-spanish-wclc-2026-highlights","url":"https://soundcloud.com/lungcancerconsidered/lcc-in-spanish-wclc-2026","duration_seconds":2935,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/lung-cancer-considered-246259/episodes/lcc-in-spanish-wclc-2026-highlights/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/lung-cancer-considered-246259/lcc-in-spanish-wclc-2026-highlights.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"LCC in Portuguese: WCLC 2026 Highlights","slug":"lcc-in-portuguese-wclc-2026-highlights","published_at":"2026-09-17T01:15:18+00:00","page_url":"https://stenobird.com/podcast/lung-cancer-considered-246259/lcc-in-portuguese-wclc-2026-highlights","url":"https://soundcloud.com/lungcancerconsidered/lcc-in-portuguese-wclc-2026","duration_seconds":1740,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/lung-cancer-considered-246259/episodes/lcc-in-portuguese-wclc-2026-highlights/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/lung-cancer-considered-246259/lcc-in-portuguese-wclc-2026-highlights.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Live From WCLC 2026: Tuesday Highlights & Meeting Summary","slug":"live-from-wclc-2026-tuesday-highlights-meeting-summary","published_at":"2026-09-15T22:15:20+00:00","page_url":"https://stenobird.com/podcast/lung-cancer-considered-246259/live-from-wclc-2026-tuesday-highlights-meeting-summary","url":"https://soundcloud.com/lungcancerconsidered/live-from-wclc-2026-tuesday","duration_seconds":2677,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/lung-cancer-considered-246259/episodes/live-from-wclc-2026-tuesday-highlights-meeting-summary/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/lung-cancer-considered-246259/live-from-wclc-2026-tuesday-highlights-meeting-summary.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"LCC in Mandarin: WCLC 2026 Highlights","slug":"lcc-in-mandarin-wclc-2026-highlights","published_at":"2026-09-15T05:58:11+00:00","page_url":"https://stenobird.com/podcast/lung-cancer-considered-246259/lcc-in-mandarin-wclc-2026-highlights","url":"https://soundcloud.com/lungcancerconsidered/lcc-in-mandarin-wclc-2026","duration_seconds":2232,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/lung-cancer-considered-246259/episodes/lcc-in-mandarin-wclc-2026-highlights/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/lung-cancer-considered-246259/lcc-in-mandarin-wclc-2026-highlights.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Live From WCLC 2026: Monday Highlights","slug":"live-from-wclc-2026-monday-highlights","published_at":"2026-09-14T23:28:09+00:00","page_url":"https://stenobird.com/podcast/lung-cancer-considered-246259/live-from-wclc-2026-monday-highlights","url":"https://soundcloud.com/lungcancerconsidered/live-from-wclc-2026-monday","duration_seconds":1878,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/lung-cancer-considered-246259/episodes/live-from-wclc-2026-monday-highlights/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/lung-cancer-considered-246259/live-from-wclc-2026-monday-highlights.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Live From WCLC 2026: Sunday Highlights","slug":"live-from-wclc-2026-sunday-highlights","published_at":"2026-09-14T01:45:34+00:00","page_url":"https://stenobird.com/podcast/lung-cancer-considered-246259/live-from-wclc-2026-sunday-highlights","url":"https://soundcloud.com/lungcancerconsidered/live-from-wclc-2026-sunday","duration_seconds":2827,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/lung-cancer-considered-246259/episodes/live-from-wclc-2026-sunday-highlights/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/lung-cancer-considered-246259/live-from-wclc-2026-sunday-highlights.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Before You Go: A Practical Guide to WCLC 2026 in Seoul","slug":"before-you-go-a-practical-guide-to-wclc-2026-in-seoul","published_at":"2026-09-04T13:00:36+00:00","page_url":"https://stenobird.com/podcast/lung-cancer-considered-246259/before-you-go-a-practical-guide-to-wclc-2026-in-seoul","url":"https://soundcloud.com/lungcancerconsidered/before-your-go-a-practical","duration_seconds":2307,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/lung-cancer-considered-246259/episodes/before-you-go-a-practical-guide-to-wclc-2026-in-seoul/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/lung-cancer-considered-246259/before-you-go-a-practical-guide-to-wclc-2026-in-seoul.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Beyond Stage IV: Rethinking Oligometastatic Lung Cancer","slug":"beyond-stage-iv-rethinking-oligometastatic-lung-cancer","published_at":"2026-09-01T13:00:21+00:00","page_url":"https://stenobird.com/podcast/lung-cancer-considered-246259/beyond-stage-iv-rethinking-oligometastatic-lung-cancer","url":"https://soundcloud.com/lungcancerconsidered/iaslc-virtual-tumor-board","duration_seconds":2850,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/lung-cancer-considered-246259/episodes/beyond-stage-iv-rethinking-oligometastatic-lung-cancer/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/lung-cancer-considered-246259/beyond-stage-iv-rethinking-oligometastatic-lung-cancer.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"LCC in Korean: The Role of Immunotherapy in Lung Cancer","slug":"lcc-in-korean-the-role-of-immunotherapy-in-lung-cancer","published_at":"2026-08-28T13:00:41+00:00","page_url":"https://stenobird.com/podcast/lung-cancer-considered-246259/lcc-in-korean-the-role-of-immunotherapy-in-lung-cancer","url":"https://soundcloud.com/lungcancerconsidered/lcc-in-korean-the-role-of","duration_seconds":2802,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/lung-cancer-considered-246259/episodes/lcc-in-korean-the-role-of-immunotherapy-in-lung-cancer/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/lung-cancer-considered-246259/lcc-in-korean-the-role-of-immunotherapy-in-lung-cancer.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"The Global Fight Against Lung Cancer: A Conversation with WHO's José Luis Castro","slug":"the-global-fight-against-lung-cancer-a-conversation-with-who-s-jos-luis-castro","published_at":"2026-08-25T13:00:21+00:00","page_url":"https://stenobird.com/podcast/lung-cancer-considered-246259/the-global-fight-against-lung-cancer-a-conversation-with-who-s-jos-luis-castro","url":"https://soundcloud.com/lungcancerconsidered/iaslc-jose-luis-castro","duration_seconds":1764,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/lung-cancer-considered-246259/episodes/the-global-fight-against-lung-cancer-a-conversation-with-who-s-jos-luis-castro/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/lung-cancer-considered-246259/the-global-fight-against-lung-cancer-a-conversation-with-who-s-jos-luis-castro.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"LCC: Grace Under Pressure: Navigating Burnout and Loss in Oncology","slug":"lcc-grace-under-pressure-navigating-burnout-and-loss-in-oncology","published_at":"2026-08-18T13:00:51+00:00","page_url":"https://stenobird.com/podcast/lung-cancer-considered-246259/lcc-grace-under-pressure-navigating-burnout-and-loss-in-oncology","url":"https://soundcloud.com/lungcancerconsidered/lcc-grace-under-pressure","duration_seconds":2834,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/lung-cancer-considered-246259/episodes/lcc-grace-under-pressure-navigating-burnout-and-loss-in-oncology/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/lung-cancer-considered-246259/lcc-grace-under-pressure-navigating-burnout-and-loss-in-oncology.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"LCC Advances in ALK+ Cancer in Cantonese","slug":"lcc-advances-in-alk-cancer-in-cantonese","published_at":"2026-08-14T13:00:59+00:00","page_url":"https://stenobird.com/podcast/lung-cancer-considered-246259/lcc-advances-in-alk-cancer-in-cantonese","url":"https://soundcloud.com/lungcancerconsidered/lcc-advances-in-alk-cancer-in","duration_seconds":2786,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/lung-cancer-considered-246259/episodes/lcc-advances-in-alk-cancer-in-cantonese/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/lung-cancer-considered-246259/lcc-advances-in-alk-cancer-in-cantonese.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Treating Advanced Thymic Cancers","slug":"treating-advanced-thymic-cancers","published_at":"2026-08-04T12:59:59+00:00","page_url":"https://stenobird.com/podcast/lung-cancer-considered-246259/treating-advanced-thymic-cancers","url":"https://soundcloud.com/lungcancerconsidered/iaslc-management-of-thymic","duration_seconds":3563,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/lung-cancer-considered-246259/episodes/treating-advanced-thymic-cancers/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/lung-cancer-considered-246259/treating-advanced-thymic-cancers.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"FDA Approval: Zidesamtinib and ROS1 NSCLC","slug":"fda-approval-zidesamtinib-and-ros1-nsclc","published_at":"2026-07-28T13:00:36+00:00","page_url":"https://stenobird.com/podcast/lung-cancer-considered-246259/fda-approval-zidesamtinib-and-ros1-nsclc","url":"https://soundcloud.com/lungcancerconsidered/fda-approval-zidesamtinib-and","duration_seconds":1441,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/lung-cancer-considered-246259/episodes/fda-approval-zidesamtinib-and-ros1-nsclc/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/lung-cancer-considered-246259/fda-approval-zidesamtinib-and-ros1-nsclc.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Rewriting the Playbook: Cellular Therapy and Vaccines for ALK-Positive Lung Cancer","slug":"rewriting-the-playbook-cellular-therapy-and-vaccines-for-alk-positive-lung-cancer","published_at":"2026-07-21T13:01:04+00:00","page_url":"https://stenobird.com/podcast/lung-cancer-considered-246259/rewriting-the-playbook-cellular-therapy-and-vaccines-for-alk-positive-lung-cancer","url":"https://soundcloud.com/lungcancerconsidered/iaslc-cell-therapy-and","duration_seconds":2859,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/lung-cancer-considered-246259/episodes/rewriting-the-playbook-cellular-therapy-and-vaccines-for-alk-positive-lung-cancer/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/lung-cancer-considered-246259/rewriting-the-playbook-cellular-therapy-and-vaccines-for-alk-positive-lung-cancer.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"IASLC - Your First Faculty Job","slug":"iaslc-your-first-faculty-job","published_at":"2026-07-07T13:00:36+00:00","page_url":"https://stenobird.com/podcast/lung-cancer-considered-246259/iaslc-your-first-faculty-job","url":"https://soundcloud.com/lungcancerconsidered/iaslc-your-first-faculty-job","duration_seconds":2518,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/lung-cancer-considered-246259/episodes/iaslc-your-first-faculty-job/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/lung-cancer-considered-246259/iaslc-your-first-faculty-job.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Game Changers & Hard Truths: Dr. Balazs Halmos Unfiltered","slug":"game-changers-hard-truths-dr-balazs-halmos-unfiltered","published_at":"2026-06-23T13:00:22+00:00","page_url":"https://stenobird.com/podcast/lung-cancer-considered-246259/game-changers-hard-truths-dr-balazs-halmos-unfiltered","url":"https://soundcloud.com/lungcancerconsidered/leading-with-purpose-lessons","duration_seconds":2754,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/lung-cancer-considered-246259/episodes/game-changers-hard-truths-dr-balazs-halmos-unfiltered/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/lung-cancer-considered-246259/game-changers-hard-truths-dr-balazs-halmos-unfiltered.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Welcome to Seoul: 2026 World Conference on Lung Cancer (WCLC) Preview","slug":"welcome-to-seoul-2026-world-conference-on-lung-cancer-wclc-preview","published_at":"2026-06-12T13:00:19+00:00","page_url":"https://stenobird.com/podcast/lung-cancer-considered-246259/welcome-to-seoul-2026-world-conference-on-lung-cancer-wclc-preview","url":"https://soundcloud.com/lungcancerconsidered/welcome-to-seoul-2026-world","duration_seconds":2356,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/lung-cancer-considered-246259/episodes/welcome-to-seoul-2026-world-conference-on-lung-cancer-wclc-preview/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/lung-cancer-considered-246259/welcome-to-seoul-2026-world-conference-on-lung-cancer-wclc-preview.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"ASCO 2026 Highlights – Part 2: Emerging Immunotherapy Strategies in Lung Cancer","slug":"asco-2026-highlights-part-2-emerging-immunotherapy-strategies-in-lung-cancer","published_at":"2026-06-09T13:00:43+00:00","page_url":"https://stenobird.com/podcast/lung-cancer-considered-246259/asco-2026-highlights-part-2-emerging-immunotherapy-strategies-in-lung-cancer","url":"https://soundcloud.com/lungcancerconsidered/asco-2026-highlights-part-2","duration_seconds":2418,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/lung-cancer-considered-246259/episodes/asco-2026-highlights-part-2-emerging-immunotherapy-strategies-in-lung-cancer/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/lung-cancer-considered-246259/asco-2026-highlights-part-2-emerging-immunotherapy-strategies-in-lung-cancer.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"ASCO 2026 Highlights – Part 1: Landmark Advances in Targeted Therapy","slug":"asco-2026-highlights-part-1-landmark-advances-in-targeted-therapy","published_at":"2026-06-05T13:00:53+00:00","page_url":"https://stenobird.com/podcast/lung-cancer-considered-246259/asco-2026-highlights-part-1-landmark-advances-in-targeted-therapy","url":"https://soundcloud.com/lungcancerconsidered/lcc-2026-asco-highlights-part","duration_seconds":2754,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/lung-cancer-considered-246259/episodes/asco-2026-highlights-part-1-landmark-advances-in-targeted-therapy/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/lung-cancer-considered-246259/asco-2026-highlights-part-1-landmark-advances-in-targeted-therapy.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Patients, AI, and Lung Cancer: Finding Clarity in the Noise","slug":"patients-ai-and-lung-cancer-finding-clarity-in-the-noise","published_at":"2026-05-19T13:00:21+00:00","page_url":"https://stenobird.com/podcast/lung-cancer-considered-246259/patients-ai-and-lung-cancer-finding-clarity-in-the-noise","url":"https://soundcloud.com/lungcancerconsidered/iaslc-ai-and-patient-care-1","duration_seconds":2790,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/lung-cancer-considered-246259/episodes/patients-ai-and-lung-cancer-finding-clarity-in-the-noise/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/lung-cancer-considered-246259/patients-ai-and-lung-cancer-finding-clarity-in-the-noise.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"LCC in Italian: Resectable EGFR-mutant NSCLC","slug":"lcc-in-italian-resectable-egfr-mutant-nsclc","published_at":"2026-05-08T17:51:13+00:00","page_url":"https://stenobird.com/podcast/lung-cancer-considered-246259/lcc-in-italian-resectable-egfr-mutant-nsclc","url":"https://soundcloud.com/lungcancerconsidered/lcc-in-italian-resectable-egfr","duration_seconds":2975,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/lung-cancer-considered-246259/episodes/lcc-in-italian-resectable-egfr-mutant-nsclc/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/lung-cancer-considered-246259/lcc-in-italian-resectable-egfr-mutant-nsclc.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"LCC Beyond Stage IV: Rethinking Oligometastatic Lung Cancer","slug":"lcc-beyond-stage-iv-rethinking-oligometastatic-lung-cancer","published_at":"2026-05-08T16:36:27+00:00","page_url":"https://stenobird.com/podcast/lung-cancer-considered-246259/lcc-beyond-stage-iv-rethinking-oligometastatic-lung-cancer","url":"https://soundcloud.com/lungcancerconsidered/lcc-beyond-stage-iv-rethinking","duration_seconds":2850,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/lung-cancer-considered-246259/episodes/lcc-beyond-stage-iv-rethinking-oligometastatic-lung-cancer/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/lung-cancer-considered-246259/lcc-beyond-stage-iv-rethinking-oligometastatic-lung-cancer.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"AACR 2026 Highlights: KRAS Updates","slug":"aacr-2026-highlights-kras-updates","published_at":"2026-05-05T12:00:27+00:00","page_url":"https://stenobird.com/podcast/lung-cancer-considered-246259/aacr-2026-highlights-kras-updates","url":"https://soundcloud.com/lungcancerconsidered/aacr-2026-highlights-kras","duration_seconds":2790,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/lung-cancer-considered-246259/episodes/aacr-2026-highlights-kras-updates/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/lung-cancer-considered-246259/aacr-2026-highlights-kras-updates.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}]}